Geneva, Aug. 31 -- International Clinical Trials Registry received information related to the study (NCT07779252) titled 'A Study to Assess the Effectiveness and Safety of IPN10200 in Adult Chinese Participants With Moderate to Severe Wrinkle-like Lines Between the Eyebrows' on Aug. 19.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Triple (Participant, Investigator, Outcomes Assessor).
Primary Sponsor: Ipsen
Condition:
Moderate to Severe Glabellar Lines
Intervention:
Biological: Corabotase
Recruitment Status: Not recruiting
Phase: Phase 3
Date of First Enrollment: October 1, 2026
Target Sample Size: 160
To know more, visit htt...